Technology
Health
Biotechnology

vTv Therapeutics

$1.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-6.60%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell VTVT and other stocks, options, ETFs, and crypto commission-free!

About

vTv Therapeutics Inc. Class A Common Stock, also called vTv Therapeutics, is a clinical-stage biopharmaceutical holding company. Read More The firm engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. The company was founded on April 2, 2015 and is headquartered in High Point, NC.

Employees
52
Headquarters
High Point, North Carolina
Founded
2015
Market Cap
37.44M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.87M
High Today
$1.97
Low Today
$1.83
Open Price
$1.93
Volume
190.42K
52 Week High
$6.09
52 Week Low
$0.65

Collections

Technology
Health
Biotechnology
Medical
Therapy
Biopharmaceutical
Cancer Prevention
Pharmaceutical

Earnings

-$0.44
-$0.31
-$0.19
-$0.06
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 14, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.